COMPOSITION FOR THE TREATMENT OF NASOPHARYNGEAL CARCINOMA AND USE THEREOF

Disclosed is a novel drug combination which is useful for the treatment of nasopharyngeal carcinoma, said novel drug combination comprising one or more of a farnesyl transferase inhibitor and one or more of an anthracycline.

Saved in:
Bibliographic Details
Main Authors PREVOST, GREGOIRE, BUSSON, PIERRE, VICAT, JEAN-MICHEL
Format Patent
LanguageEnglish
French
German
Published 07.01.2009
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed is a novel drug combination which is useful for the treatment of nasopharyngeal carcinoma, said novel drug combination comprising one or more of a farnesyl transferase inhibitor and one or more of an anthracycline.
Bibliography:Application Number: EP20030758540